NCT01134185View on ClinicalTrials.gov

Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Hepatic Impairment

Interventions

DRUG

prucalopride

single oral dose of 2 mg prucalopride

DRUG

prucalopride

single oral dose of 2 mg prucalopride

DRUG

prucalopride

single dose of 2 mg prucalopride

Trial Locations (1)

Unknown

Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Movetis

INDUSTRY